Li JJ, Wang ZH, Chen L, Zhang WJ, et al. Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase 2 trial. Ann Oncol 2025 Mar 4:S0923-7534(25)00082-1. doi: 10.1016/j.annonc.2025.
PMID: 40049447